Debrisoquine
From Self-sufficiency
Debrisoquine[1] | |
---|---|
File:Debrisoquine.svg | |
1,2,3,4-tetrahydroisoquinoline-2-carboximidamide | |
style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
CAS number | 1131-64-2 |
PubChem | 2966 |
ChemSpider | 2860 |
MeSH | Debrisoquine |
SMILES | Script error: No such module "collapsible list". |
InChI | Script error: No such module "collapsible list". |
InChI key | JWPGJSVJDAJRLW-UHFFFAOYAE |
style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
Molecular formula | C10H13N3 |
Molar mass | 175.23032 |
(what is this?) (verify) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
Infobox references |
Debrisoquine is a derivative of guanidine. It is an antihypertensive drug similar to guanethidine. Debrisoquine is frequently used for phenotyping the CYP2D6 enzyme, a drug metabolizing enzyme.[2]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40px | This antihypertensive-related article is a stub. You can help ssf by expanding it. |
- ↑ Debrisoquine - Compound Summary, PubChem.
- ↑ [1] Appropriate Phenotyping Procedures for Drug Metabolizing Enzymes and Transporters in Humans and Their Simultaneous Use in the "Cocktail" Approach